Back

SARM1 is required for macrophage immunophenotype switching that is essential for nerve repair

Bennett, J.; Adesunkanmi, H.; Leever, N.; Bergeron, G.; Small, J.; Holladay, C.; Saxman, G.; Williamson, R. E.; Swain, M.; Pearson, G.; Patel, M.; Kalinski, A. L.

2026-04-09 neuroscience
10.64898/2026.04.07.716973 bioRxiv
Show abstract

SARM1 is a key executor of Wallerian degeneration in axons. Global knockout of sarm1 in mice delays degeneration for several weeks. Recently, we reported that Schwann cell reprogramming, inflammation, and axon regeneration are also delayed in these animals. Several studies have also indicated that SARM1 has essential regulatory functions in macrophages (M{phi}). However, the role of SARM1 in M{phi} in the context of peripheral nerve injury remains unknown. Here, we report that loss of sarm1 impairs splenic M{phi} from adopting immunological stimuli driven immunophenotypes in culture. Through a combination of cell culture, Western blotting, gene expression analysis, in vivo injection of M{phi} into sciatic nerves, and generation of cell specific sarm1 conditional knockout mouse lines, we found that SARM1 is required for proper immunophenotypes in M{phi}. Loss of sarm1 in macrophages increases neurite length of sensory neurons in culture but delays regeneration in a model of peripheral nerve injury. We identified dysregulation of several inflammatory and anti-inflammatory immunological stimuli pathways and altered regulation of both iNOS and Arginase-1 in Sarm1-/- M{phi}. In culture, Sarm1-/- M{phi} display difficulty phagocytosing and clearing myelin debris and this was recapitulated in vivo with a M{phi} specific sarm1 knockout line. Generation of M{phi} and neuronal sarm1 conditional knockout mice further indicated that SARM1 is required in both cell types for an efficient response to peripheral nerve injury. This study provides the first evidence that SARM1 signaling in M{phi} is required for injury induced inflammation, degeneration, and axon regeneration.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
eLife
5422 papers in training set
Top 2%
14.6%
2
Cell Reports
1338 papers in training set
Top 0.9%
14.2%
3
Nature Communications
4913 papers in training set
Top 23%
8.3%
4
eneuro
389 papers in training set
Top 2%
4.8%
5
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 18%
3.9%
6
The Journal of Neuroscience
928 papers in training set
Top 4%
3.6%
7
EMBO reports
136 papers in training set
Top 1%
3.2%
50% of probability mass above
8
JCI Insight
241 papers in training set
Top 2%
2.7%
9
Developmental Cell
168 papers in training set
Top 6%
2.7%
10
Science Advances
1098 papers in training set
Top 11%
2.3%
11
Glia
74 papers in training set
Top 0.2%
2.1%
12
PLOS Genetics
756 papers in training set
Top 7%
2.1%
13
Aging Cell
144 papers in training set
Top 2%
2.1%
14
Journal of Clinical Investigation
164 papers in training set
Top 2%
1.9%
15
Neuron
282 papers in training set
Top 5%
1.8%
16
PLOS Biology
408 papers in training set
Top 9%
1.8%
17
iScience
1063 papers in training set
Top 20%
1.3%
18
Journal of Cell Biology
333 papers in training set
Top 3%
1.2%
19
Brain
154 papers in training set
Top 4%
0.9%
20
Journal of Biological Chemistry
641 papers in training set
Top 4%
0.8%
21
Immunity
58 papers in training set
Top 4%
0.8%
22
Nature Neuroscience
216 papers in training set
Top 6%
0.7%
23
Journal of Cell Science
353 papers in training set
Top 3%
0.7%
24
Frontiers in Cellular Neuroscience
79 papers in training set
Top 1%
0.7%
25
Journal of Neuroinflammation
50 papers in training set
Top 1%
0.7%
26
Human Molecular Genetics
130 papers in training set
Top 4%
0.6%
27
Cell Death & Disease
126 papers in training set
Top 3%
0.6%
28
npj Regenerative Medicine
21 papers in training set
Top 0.4%
0.6%
29
Cell Death & Differentiation
48 papers in training set
Top 1%
0.6%
30
Scientific Reports
3102 papers in training set
Top 78%
0.6%